Kiren Sehmi BSc. (Hons.) FBDO CL
Clinical Peer-Reviewed Article Summary
Lotilaner Ophthalmic Solution(TP-03), 0.25%, for the Treatment of Demodex Blepharitis: A Randomized, Double-Masked, Vehicle-Controlled,...
top of page
Kiren Sehmi BSc. (Hons.) FBDO CL
- 1 min
A Clinical Drug Intervention Presentation
Welcome to the drug intervention presentation for TP-03, a novel ophthalmic solution that offers hope to patients suffering from Demodex...
Kiren Sehmi BSc. (Hons.) FBDO CL
- 3 min
Eyes On Vaping
Vaping is an increasingly popular trend, but you may be underestimating its impact on your patients’ health. You know that it’s harmful,...
Grow Your Vision With A Tailored Approach
bottom of page